Clinical Trials Logo

Clinical Trial Summary

This open-label, adaptive-design, pilot study was designed to evaluate the effect of Onion-Pumpkin Extract in supporting healthy blood pressure as assessed by the change in systolic and diastolic blood pressures. The effect of the product on glucose metabolism, lipid levels, and antioxidant levels would also be determined. Tolerability and safety of the study product would also be investigated.


Clinical Trial Description

Hypertension has become one of the most common diseases in the world and considered a public health challenge due to its association with morbidity and mortality and increased cost to society. Hypertension is the most important risk factor for cardiovascular diseases such as coronary heart disease, stroke, congestive heart failure, and peripheral vascular disease. One fourth of adults in the United States have high blood pressure and among these, the blacks and the elderly have higher incidence of hypertension. This condition is characterized by abnormally high blood pressure with the systolic greater than 140 mmHg and diastolic greater than 90 mmHg (1).

Lowering blood pressure has been linked to 35% to 40% reductions in the incidence of stroke, 20%-25% in myocardial infarction, and 50% in heart failure. Management of hypertension includes lifestyle modifications and pharmacological therapy and antihypertensive drugs. Lifestyle modifications such as weight reduction in overweight and obese individuals, 8-week diet of fruits, vegetables, low-fat dairy products, whole grain, poultry fish and nuts with limited fats, red meat and sweets, reduction in dietary sodium, physical activity, and moderation of alcohol consumption have been shown to lower blood pressure. There are several classes of antihypertensive drugs, including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) β-blockers (BBs), calcium channel blockers (CCBs) and the thiazide-class diuretics. Among these, the diuretic based therapy was more effective than other treatments in preventing cardiovascular diseases as demonstrated by the Antihypertensive and Lipid-lowering Treatment to prevent Heart Attack (ALLHAT) trial (1, 2).

Blood pressure can be lowered without using prescription drugs. Nutraceuticals have found their application in the treatment of hypertension. Omega-3 polyunsaturated fatty acids, omega-9 fatty acids, garlic, seaweed, and various vitamins and minerals have been shown to reduce blood pressure significantly (3).

Animal studies have demonstrated the potential benefits of onion in hypertensive rats. In one study involving rats fed with a control diet or a high-fat high-sucrose diet with or without Welsh onion for 4 weeks, lower blood pressure was observed in rats with onion diet, especially the green-leafy type. In addition, these rats have higher levels of nitric oxide (NO) metabolites in the urine and plasma, lower activity of NADH/NADPH oxidase in the aorta, and suppressed angiotensin II production (4). The mechanism of the antihypertensive effect of onion probably involves increased saving of NO (4, 5). A randomized, placebo-controlled, double-blind trial also demonstrated significant decrease in arterial blood pressure and reduction in plasma viscosity five hours after administration of a formulation containing onion and olive oil (6).

Pumpkin has been used as a traditional medicine and it is known for its antidiabetic, antitumor, antibacterial, anti-inflammatory, and antihypertensive properties (7). Animal studies confirmed that pumpkin seed oil supplementation resulted in lower systolic and diastolic blood pressure as well as improvements in lipid profile in both non-ovariectomized and ovariectomized rats (8). Using enzyme assays, it was demonstrated that pumpkin have moderate to high alpha-glucosidase and ACE inhibitory activities (9). A recent clinical trial involved postmenopausal women and the effects of supplemented pumpkin seed oil in cholesterol levels. The results of this trial showed that 12-week administration of 2g/day pumpkin seed oil led to a significant increase in HDL cholesterol and significant decrease in diastolic blood pressure. Pumpkin seed oil also improved menopausal symptom scores by decreasing hot flushes, headaches, and joint pains (10).

This open-label, adaptive-design, pilot study was designed to evaluate the effect of Onion-Pumpkin Extract in supporting healthy blood pressure as assessed by the change in systolic and diastolic blood pressures. The effect of the product on glucose metabolism, lipid levels, and antioxidant levels would also be determined. Tolerability and safety of the study product would also be investigated. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02353104
Study type Interventional
Source Medicus Research, LLC
Contact
Status Completed
Phase Phase 2
Start date November 2013
Completion date August 2014

See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT05997303 - Continuous Norepinephrine Administration and Blood Pressure Stability During Anesthetic Induction N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT03918486 - Caretaker vs. Routine Blood Pressure Sphygmomanometer
Completed NCT03410342 - The Effects of Types of Fruits and Vegetables on Vascular Function N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT04087070 - Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
Completed NCT03294928 - Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers N/A
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03997461 - Comparison of Arterial Tonometry Sensor With Standard Oscillometric Blood Pressure Monitoring Device N/A
Completed NCT03290716 - Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China N/A
Recruiting NCT06460233 - Blood Pressure Changes After Bariatric Surgery
Recruiting NCT05196048 - Blood Pressure Sensor of Watch-type Device With ECG Technology
Terminated NCT03325933 - Resistance Training and Cardiometabolic Health N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02451059 - Reducing Socioeconomic Disparities in Health at Pediatric Visits N/A
Active, not recruiting NCT02670967 - Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials N/A
Completed NCT02239744 - Intervention Study on the Health Impact of Air Filters in Chinese Adults N/A
Completed NCT02271633 - Nitrate Supplementation; Source Phase 4